(IMAGE)
Caption
The proposed Fe-EGCG@RSL3 system can be easily synthesized through the self-assembly of its basic ingredients. It can be administered either into the bladder or through the bloodstream, since the nanomedicine preferentially targets tumor cells. In addition to directly killing cancer cells through ferroptosis, Fe-EGCG@RSL3 modulates the tumor immune microenvironment in beneficial ways, making immunotherapy more effective.
Credit
Dr. Chengjunyu Zhang from Sun Yat-Sen University, China
Usage Restrictions
Credit must be given to the creator.
License
CC BY